Lista de obras - Sabela Lens - Dominio Público Uruguay

"Safety of Hepatitis C Virus (HCV) treated donors for kidney transplantation (KT) excluding occult HCV infection through kidney biopsies."

artículo científico publicado en 2018

Advances in hepatitis C therapies

artículo científico

Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone

artículo científico publicado en 2018

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment.

artículo científico publicado en 2017

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

artículo científico publicado en 2015

Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy

artículo científico publicado en 2015

Beyond the achievement of sustained virological response after liver transplantation.

artículo científico publicado en 2015

Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid

scientific article published on 02 September 2013

Challenges in Special Populations: HIV/HCV Coinfection, Liver Transplantation and Patients with End-Stage Renal Disease.

artículo científico publicado en 2016

Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8+ T cells after direct-acting antiviral therapies

artículo científico publicado en 2020

Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

artículo científico publicado en 2016

Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation

artículo científico publicado en 2012

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

artículo científico publicado en 2016

Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis

artículo científico publicado en 2018

Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection

scientific article published on 01 October 2018

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

artículo científico publicado en 2017

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

artículo científico publicado en 2016

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

artículo científico publicado en 2016

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

artículo científico publicado en 2017

Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.

artículo científico publicado en 2017

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

artículo científico publicado en 2018

Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease

artículo científico publicado en 2014

Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort

artículo científico publicado en 2018

Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns

artículo científico publicado en 2017

Future prospects for hepatitis C treatment: without interferon and ribavirin?

artículo científico publicado en 2014

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.

artículo científico publicado en 2017

HEV infection in two referral centers in Spain: epidemiology and clinical outcomes.

artículo científico publicado en 2014

Hepatitis A outbreak in Barcelona among men who have sex with men (MSM), January - June 2017: a hospital perspective.

artículo científico publicado en 2017

Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen

artículo científico publicado en 2017

Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals

scholarly article by Elena Perpiñán published in October 2018

Hepatitis E-induced acute-on-chronic liver failure and VI nerve paralysis

artículo científico publicado en 2018

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

artículo científico publicado en 2015

Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodies

scientific article published on 09 January 2020

Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.

artículo científico publicado en 2010

Improvement of sexuality after hepatitis C cure with direct acting antivirals

scientific article published on 07 October 2020

Interferon free regimens for the “difficult-to-treat”: Are we there? ⬇️

artículo científico publicado el 16 de enero de 2013

Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease

artículo científico publicado en 2017

Interferon-free regimens in the liver-transplant setting

artículo científico

Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C.

artículo científico publicado en 2014

Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure

artículo científico publicado en 2018

Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

artículo científico publicado en 2019

Low seroprevalence and zero incidence rate of hepatitis E in men who have sex with men during a hepatitis A outbreak

scientific article published on 19 November 2019

Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy

artículo científico publicado en 2016

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.

artículo científico publicado en 2016

Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals

scientific article published on 17 October 2019

Potential Drug-Drug Interactions of Ombitasvir, Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin in Clinical Practice.

artículo científico publicado en 2017

Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C.

artículo científico publicado en 2015

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

artículo científico publicado en 2017

Reply

Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct-acting anti-virals

scientific article published on 15 April 2020

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

artículo científico publicado en 2015

Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.

artículo científico publicado en 2018

Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals

scientific article published on 20 January 2020

Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

artículo científico publicado en 2016

Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation.

artículo científico publicado en 2015

Simplified follow-up of patients with mild chronic hepatitis C in areas with limited access to antiviral therapy

article published in 2018

The HBeAg-Negative "Gray Zone" Phase: A Frequent Condition With Different Outcomes in Western and Asian Patients?

scientific article published on 01 January 2020

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis

artículo científico publicado en 2014

Treating Hepatitis C in Patients with Renal Failure.

artículo científico publicado en 2017

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

artículo científico publicado en 2017

Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation

artículo científico publicado en 2014

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

artículo científico publicado en 2016

Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)

artículo científico publicado en 2012

Usefulness of liver stiffness measurement after antiviral response in chronic hepatitis C

artículo científico publicado en 2013

Viral hepatitis and liver transplantation: pathogenesis, prevention and therapy of recurrent disease.

artículo científico

Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals

artículo científico publicado en 2016

[Cost-efficacy of new antiviral treatments for chronic hepatitis C]

artículo científico publicado en 2015

[Elastography of the liver (Fibroscan®) in hepatology]

scientific article published on 01 April 2013

[Liver abscesses following liver transplantation from non-heart-beating donation]

artículo científico publicado en 2010

Lista de obras de Sabela Lens

"Safety of Hepatitis C Virus (HCV) treated donors for kidney transplantation (KT) excluding occult HCV infection through kidney biopsies."

Advances in hepatitis C therapies

Anti-viral therapy can be delayed or avoided in a significant proportion of HBeAg-negative Caucasian patients in the Grey Zone

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment.

Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy

Beyond the achievement of sustained virological response after liver transplantation.

Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid

Challenges in Special Populations: HIV/HCV Coinfection, Liver Transplantation and Patients with End-Stage Renal Disease.

Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8+ T cells after direct-acting antiviral therapies

Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy.

Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation

Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current Methods

Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis

Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection

Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma

Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.

Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis

Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease

Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort

Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns

Future prospects for hepatitis C treatment: without interferon and ribavirin?

Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.

HEV infection in two referral centers in Spain: epidemiology and clinical outcomes.

Hepatitis A outbreak in Barcelona among men who have sex with men (MSM), January - June 2017: a hospital perspective.

Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen

Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals

Hepatitis E-induced acute-on-chronic liver failure and VI nerve paralysis

High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods

Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodies

Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.

Improvement of sexuality after hepatitis C cure with direct acting antivirals

Interferon free regimens for the “difficult-to-treat”: Are we there? ⬇️

Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease

Interferon-free regimens in the liver-transplant setting

Liver stiffness 1 year after transplantation predicts clinical outcomes in patients with recurrent hepatitis C.

Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure

Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

Low seroprevalence and zero incidence rate of hepatitis E in men who have sex with men during a hepatitis A outbreak

Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy

Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.

Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals

Potential Drug-Drug Interactions of Ombitasvir, Paritaprevir/Ritonavir ± Dasabuvir ± Ribavirin in Clinical Practice.

Predicting the development of liver cirrhosis by simple modelling in patients with chronic hepatitis C.

Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection

Reply

Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct-acting anti-virals

Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment.

Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.

Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals

Simeprevir in combination with sofosbuvir in treatment-naïve and -experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open-label, single-arm study (PLUTO).

Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation.

Simplified follow-up of patients with mild chronic hepatitis C in areas with limited access to antiviral therapy

The HBeAg-Negative "Gray Zone" Phase: A Frequent Condition With Different Outcomes in Western and Asian Patients?

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis

Treating Hepatitis C in Patients with Renal Failure.

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry.

Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)

Usefulness of liver stiffness measurement after antiviral response in chronic hepatitis C

Viral hepatitis and liver transplantation: pathogenesis, prevention and therapy of recurrent disease.

Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals

[Cost-efficacy of new antiviral treatments for chronic hepatitis C]

[Elastography of the liver (Fibroscan®) in hepatology]

[Liver abscesses following liver transplantation from non-heart-beating donation]